Double-Blind, Four Week Trial Of [S,S]-Reboxetine And Atomoxetine In Adults With Attention Deficit Hyperactivity Disorder.
Status:
Withdrawn
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This study will compare the safety and efficacy of [S,S]-reboxetine to atomoxetine in the
treatment of adult patients with attention deficity-hyperactivity disorder.